Prefilled Syringes Market Analysis

  • Report ID: 4398
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Prefilled Syringes Market Analysis

Application (Diabetes, Multiple Sclerosis, Anaphylaxis, Cancer)

The global prefilled syringes market is segmented and analyzed for demand and supply by application into diabetes, multiple sclerosis, anaphylaxis, cancer and others. Out of the five applications of prefilled syringes, the diabetes segment is estimated to gain the largest market share of about 54% in the year 2037. The growth of the segment can be attributed to the increasing prevalence of diabetes across the globe. The need for pre-filled syringes and insulin is expected to rise along with the prevalence of diabetes. For instance, insulin shots are necessary to maintain normal blood sugar levels in patients with diabetes. Pre-filled syringes offer a quick and convenient way to inject insulin at home or on the go for patients with diabetes who need frequent dosage. Further, the rising popularity of self-medication is projected to boost demand for pre-filled syringes among diabetic patients as it decreases the need for frequent trips to medical facilities. According to estimates, diabetes affected over 37 million Americans in 2019.

Material (Glass-Based, Plastic Based)

The global prefilled syringes market is also segmented and analyzed for demand and supply by material into glass-based, and plastic based. Amongst these two segments, the glass-based segment is expected to garner a significant share of around 54% in the year 2037. Drug makers prefer glass-based prefilled syringes owing to their superior barrier qualities. Oxygen and water vapor are shielded from drug molecules by the barrier qualities of glass. For instance, glass is utilized in over 90% of PFSs. Besides this, glass provides long-term drug stability for biopharmaceuticals. This, as a result, is anticipated to create numerous opportunities for the growth of the segment in the coming years.

Our in-depth analysis of the global market includes the following segments:

       By Design

  • Single-Chamber
  • Dual Chamber
  • Customized

      By Material

  • Glass-Based
  • Plastic Based

     By Application

  • Diabetes
  • Multiple Sclerosis
  • Anaphylaxis
  • Cancer
  • Others
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 4398
  • Published Date: Oct 10, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of prefilled syringes is estimated at USD 19.94 billion.

The prefilled syringes market size was over USD 18 billion in 2024 and is expected to cross USD 93.48 billion by the end of 2037, growing at more than 13.4% CAGR during the forecast period i.e., between 2025-2037. Increasing prevalence of HIV and hepatitis-B cases and the rise in demand of self-injection devices will boost the market growth.

Europe is predicted to be the largest with a share of about 41% by 2037, attributed to increasing geriatric population.

The major players in the market include Abbott, Bayer Pharmaceuticals, Baxter BioPharma Solutions, BG (Becton, Dickinson and Company), Gerresheimer AG, Medtronic, Nipro Pharma Corporation, Terumo Medical Corporation, Vetter Pharma International GmbH, West Pharmaceutical Services, Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample